BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36906605)

  • 21. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
    Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
    Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ-ABCB10 acts as an oncogene in glioma cells via regulation of the miR-620/FABP5 axis.
    Sun WY; Lu YF; Cai XL; Li ZZ; Lv J; Xiang YA; Chen JJ; Chen WJ; Liu XM; Chen JB
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6848-6857. PubMed ID: 32633377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
    Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
    Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis.
    Kawaguchi K; Kinameri A; Suzuki S; Senga S; Ke Y; Fujii H
    Biochem J; 2016 Feb; 473(4):449-61. PubMed ID: 26614767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
    Han W; Yu G; Meng X; Hong H; Zheng L; Wu X; Zhang D; Yan B; Ma Y; Li X; Wang Q
    Mol Cell Biochem; 2019 Oct; 460(1-2):37-51. PubMed ID: 31222560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].
    Lin YX; Chen K; An FM; Wang YF; Wu XB; Zhan Q; Zhang GQ
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1006-1013. PubMed ID: 34814397
    [No Abstract]   [Full Text] [Related]  

  • 30. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
    Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
    Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
    Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.
    Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
    Zhang L; Zhao Y; Guan H; Zhang D
    Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-ÎșB) signaling in cancer cells.
    Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
    Liu Y; Liu J; Cui J; Zhong R; Sun G
    Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
    Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
    Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
    Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.